v5 custom microarray chip (23andMe)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

23andMe v5 custom microarray chip
V5 Custom Microarray Chip, supplied by 23andMe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+customized+microarray+chips/genetic+test/pm37311868-59-18-17
Average 90 stars, based on 1 article reviews

v5 custom microarray chip - by Bioz Stars, 2026-11

90/100 stars

Images

Activation Assay:

Article Title: Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1.
Article Snippet: Specifically, the PRS for MDD (with 23andMe) was nominally associated with increased probability of remission (OR = 1.86 [1.19–2.91], p-value= 0.007, empirical p-value= 0.025) and better symptom improvement (Beta (SE)= 5.56 (2.24), p-value= 0.014, empirical p-value= 0.04).

Article Title: Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1.
Article Snippet: For the ESC-only group (n= 64), the PRS for MDD (with 23andMe) was associated with an increased probability of remission (OR= 3.69 [1.40–9.73], p-value= 0.008, empirical p-value= 0.034) and better symptom improvement (Beta (SE)= 7.65 (2.68), p-value= 0.006, empirical p-value = 0.02).

Article Title: 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
Article Snippet: Corresponding Author: Kimberline Y. Gerrick, 23andMe, Inc. Therapeutics, 349 Oyster Point Blvd, South San Francisco, CA 94080.

Article Title: [Genetic factors underlying the susceptibility to SARS-CoV-2 infection and severe COVID-19].
Article Snippet: A 23andMe vállalat több mint 1 millió résztvevővel végzett genetikai vizsgálata [15], valamint a Host Genetics Initiative konzorcium által végzett vizsgálat [7] nagyon hasonló hatásméreteket jelentett a fertőzésre való hajlam és a betegség súlyosságának fenotípusaira.

Article Title: Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l’aide des scores de risque polygéniques : Rapport sur l’étude CAN-BIND-1
Article Snippet: Specifically, the PRS for MDD (with 23andMe) was nominally associated with increased probability of remission (OR = 1.86 [1.19–2.91], p -value = 0.007, empirical p -value = 0.025) and better symptom improvement (Beta ( SE ) = 5.56 (2.24), p -value = 0.014, empirical p -value = 0.04).

Article Title: Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l’aide des scores de risque polygéniques : Rapport sur l’étude CAN-BIND-1
Article Snippet: For the ESC-only group ( n = 64), the PRS for MDD (with 23andMe) was associated with an increased probability of remission (OR = 3.69 [1.40–9.73], p -value = 0.008, empirical p -value = 0.034) and better symptom improvement (Beta ( SE ) = 7.65 (2.68), p -value = 0.006, empirical p -value = 0.02).

Article Title: Multidisciplinary stakeholder-informed identification of key characteristics for implementation of workplace genetic testing.
Article Snippet: Other recent events, such as 23andMe’s data breach and bankruptcy announcement have shed light into the challenges of trusting private companies, outside the healthcare arena, with sensitive genetic data59-61.

Review

v5 custom microarray chip (23andMe)

Structured Review

Images

Related Articles

Activation Assay:

Similar Products

Image Search Results